Cargando…
Survival Trends and Long-Term Toxicity in Pediatric Patients with Osteosarcoma
Background. This study was conducted to investigate the clinical characteristics and treatment results of osteosarcoma in pediatric patients during the past 30 years. Trends in survival rates and long-term toxicity were analyzed. Procedure. 130 pediatric patients under the age of 20 years with prima...
Autores principales: | Hagleitner, Melanie M., de Bont, Eveline S. J. M., te Loo, D. Maroeska W. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512330/ https://www.ncbi.nlm.nih.gov/pubmed/23226967 http://dx.doi.org/10.1155/2012/636405 |
Ejemplares similares
-
Early toxicity predicts long-term survival in high-grade glioma
por: Lawrence, Y R, et al.
Publicado: (2011) -
Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities
por: Hurkmans, Evelien G. E., et al.
Publicado: (2020) -
Pharmacogenetics of chemotherapy treatment response and -toxicities in patients with osteosarcoma: a systematic review
por: Hurkmans, Evelien G. E., et al.
Publicado: (2022) -
Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer: Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts
por: Hagleitner, Melanie M., et al.
Publicado: (2014) -
Pharmacogenomics as a Tool to Limit Acute and Long-Term Adverse Effects of Chemotherapeutics: An Update in Pediatric Oncology
por: Bernsen, Emma C., et al.
Publicado: (2020)